Showing results (41-50 of 304) with videos related to

Sort By:
Pageof 31
Seminars in Thrombosis and Hemostasis|January 1, 1994
Hemostatic system activation in patients with lupus anticoagulant and essential thrombocythemiaA Falanga, F A Ofosu, S Cortelazzo, et al.
American Journal of Hematology|April 17, 1998
Aspirin increases the bleeding side effects in essential thrombocythemia independent of the cyclooxygenase pathway: role of the lipoxygenase pathwayS Cortelazzo, M Marchetti, E Orlando, et al.
La Ricerca in Clinica E in Laboratorio|January 1, 1987
Association between lupus anticoagulant and epilepsyG Finazzi, M Galli, P Viero, et al.
Haemostasis|January 1, 1990
Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disordersM Romano, P Viero, S Cortellazzo, et al.
Fertility and Sterility|October 1, 1988
Antiphospholipid antibodies in early repeated abortions: a case-controlled studyT Barbui, S Cortelazzo, M Galli, et al.
The New England Journal of Medicine|April 27, 1995
Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosisS Cortelazzo, G Finazzi, M Ruggeri, et al.
Thrombosis and Haemostasis|November 1, 1995
Increased thromboxane biosynthesis in essential thrombocythemiaB Rocca, G Ciabattoni, R Tartaglione, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term results of the HEAVD protocol for adult acute lymphoblastic leukaemiaR Bassan, R Battista, A D'Emilio, et al.
Hematological Oncology|January 1, 1991
Short-term remission induction and consolidation therapy for adult acute myelogenous leukemiaR Battista, R Bassan, A D'Emilio, et al.
Scandinavian Journal of Haematology|August 1, 1986
Large granular lymphocyte/natural killer cell proliferative disease: clinical and laboratory heterogeneityR Bassan, M Introna, A Rambaldi, et al.
Pageof 31